Search Results - Langmia, I. M.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Role of pharmacodiagnostic of CYP2C9 variants in the optimization of warfarin therapy in Malaysia: a 6-month follow-up study

    Role of pharmacodiagnostic of CYP2C9 variants in the optimization of warfarin therapy in Malaysia: a 6-month follow-up study by Ngow, Harris Abdullah, Teh , Lay Kek, Langmia, I. M., Lew, W. L., Harun, R., Ismail, R., Salleh, Mohd Zaki

    Published 2008
    Get full text
    Get full text
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin

    Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin by Teh, L. K., Langmia, I. M., M. H., Fazleen Haslinda, Ngow, Harris Abdullah, Roziah, M. J., Harun, R., Zakaria, Z. A., Salleh, M. Z.

    Published 2011
    Get full text
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: